Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients

Table 2

The screened gene sets and pathways after univariable Cox regression analysis.

Gene sets and pathways	HR	HR.95L	HR.95H	value
T_GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN	5.03	4.94	5.23	0.003
T_GSE20715_0H_VS_48H_OZONE_LUNG_DN	2.92	3.04	1.17	0.005
T_GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP	3.73	1.92	7.74	0.014
T_HALLMARK_GLYCOLYSIS	8.97	8.43	9.25	0.001
T_GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN	2.89	2.15	3.87	0.002